Boston Partners lowered its position in Anthem, Inc. (NYSE:ANTM) by 2.0% during the second quarter, Holdings Channel reports. The firm owned 3,819,575 shares of the company’s stock after selling 76,288 shares during the period. Anthem comprises about 0.9% of Boston Partners’ investment portfolio, making the stock its 21st largest position. Boston Partners’ holdings in Anthem were worth $718,577,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. FTB Advisors Inc. raised its stake in shares of Anthem by 11.1% in the first quarter. FTB Advisors Inc. now owns 668 shares of the company’s stock worth $117,000 after buying an additional 67 shares during the period. Westside Investment Management Inc. raised its stake in shares of Anthem by 33.6% in the first quarter. Westside Investment Management Inc. now owns 795 shares of the company’s stock worth $131,000 after buying an additional 200 shares during the period. Focused Wealth Management Inc bought a new stake in shares of Anthem during the first quarter worth about $149,000. Cedar Wealth Management LLC raised its stake in shares of Anthem by 1.7% in the second quarter. Cedar Wealth Management LLC now owns 908 shares of the company’s stock worth $171,000 after buying an additional 15 shares during the period. Finally, Guardian Life Insurance Co. of America raised its stake in shares of Anthem by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,016 shares of the company’s stock worth $168,000 after buying an additional 7 shares during the period. 89.81% of the stock is currently owned by institutional investors.

Shares of Anthem, Inc. (NYSE:ANTM) opened at 192.85 on Thursday. Anthem, Inc. has a 1-year low of $114.85 and a 1-year high of $194.94. The company has a market cap of $50.64 billion, a P/E ratio of 18.24 and a beta of 0.73. The stock’s 50 day moving average price is $190.01 and its 200 day moving average price is $175.67.

Anthem (NYSE:ANTM) last announced its quarterly earnings results on Wednesday, July 26th. The company reported $3.37 earnings per share for the quarter, topping analysts’ consensus estimates of $3.23 by $0.14. The firm had revenue of $22.20 billion for the quarter, compared to the consensus estimate of $22.25 billion. Anthem had a return on equity of 12.93% and a net margin of 3.24%. The business’s revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.33 earnings per share. Equities research analysts forecast that Anthem, Inc. will post $11.82 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date of this dividend is Thursday, September 7th. This is an increase from Anthem’s previous quarterly dividend of $0.65. Anthem’s payout ratio is 24.62%.

ILLEGAL ACTIVITY NOTICE: “Anthem, Inc. (NYSE:ANTM) Stake Decreased by Boston Partners” was reported by Daily Political and is the property of of Daily Political. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/10/anthem-inc-nyseantm-stake-decreased-by-boston-partners.html.

A number of equities research analysts have recently issued reports on the company. BidaskClub lowered Anthem from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $215.00 target price (up from $210.00) on shares of Anthem in a research report on Wednesday, July 26th. Deutsche Bank AG boosted their target price on Anthem from $173.00 to $185.00 and gave the stock a “hold” rating in a research report on Thursday, July 13th. Jefferies Group LLC reaffirmed a “hold” rating and set a $183.00 target price (up from $177.00) on shares of Anthem in a research report on Sunday, April 23rd. Finally, Morgan Stanley started coverage on Anthem in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $196.00 price target on the stock. Twelve research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Anthem has a consensus rating of “Hold” and an average target price of $180.00.

In other Anthem news, SVP Ronald W. Penczek sold 867 shares of the business’s stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $187.46, for a total transaction of $162,527.82. Following the transaction, the senior vice president now owns 1,872 shares of the company’s stock, valued at $350,925.12. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, Director Julie A. Hill sold 555 shares of the business’s stock in a transaction that occurred on Wednesday, May 24th. The stock was sold at an average price of $180.56, for a total value of $100,210.80. Following the transaction, the director now directly owns 37,448 shares in the company, valued at approximately $6,761,610.88. The disclosure for this sale can be found here. In the last three months, insiders have sold 4,103 shares of company stock worth $749,555. Company insiders own 0.36% of the company’s stock.

Anthem Company Profile

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.